Abstract
Protein misfolding and aggregation into nano-scale ordered amyloid fibrils is one of the most exciting field of Biochemistry. The correct folding is essential for function of proteins and thus, existence of living systems. An effective protein quality control in living system recognizes and degrades misfolded protein quickly and prevents aggregation. Dysfunction or impaired function of this quality control system may result in deposition of protein aggregates. A number of diseases have been linked to deposition of insoluble amyloid aggregates in the brain or other organs. Recently, researchers have reported nano-based therapeutic options and early detection techniques for amyloid diseases. Moreover, thermodynamics of misfolding and aggregation has provided important clue for drug development. Researchers across the globe are working on the development of therapeutic strategies to combat protein aggregation diseases. In the current review, we aim to bring together recent developments about protein misfolding, aggregation and therapeutics against protein misfolding/ aggregation diseases.
Keywords: Protein folding, diseases, nano-fibrils
Current Proteomics
Title: Protein Nano-Fibrilar Structure and Associated Diseases
Volume: 7 Issue: 2
Author(s): Nandini Sarkar and Vikash Kumar Dubey
Affiliation:
Keywords: Protein folding, diseases, nano-fibrils
Abstract: Protein misfolding and aggregation into nano-scale ordered amyloid fibrils is one of the most exciting field of Biochemistry. The correct folding is essential for function of proteins and thus, existence of living systems. An effective protein quality control in living system recognizes and degrades misfolded protein quickly and prevents aggregation. Dysfunction or impaired function of this quality control system may result in deposition of protein aggregates. A number of diseases have been linked to deposition of insoluble amyloid aggregates in the brain or other organs. Recently, researchers have reported nano-based therapeutic options and early detection techniques for amyloid diseases. Moreover, thermodynamics of misfolding and aggregation has provided important clue for drug development. Researchers across the globe are working on the development of therapeutic strategies to combat protein aggregation diseases. In the current review, we aim to bring together recent developments about protein misfolding, aggregation and therapeutics against protein misfolding/ aggregation diseases.
Export Options
About this article
Cite this article as:
Sarkar Nandini and Kumar Dubey Vikash, Protein Nano-Fibrilar Structure and Associated Diseases, Current Proteomics 2010; 7 (2) . https://dx.doi.org/10.2174/157016410791330516
DOI https://dx.doi.org/10.2174/157016410791330516 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeo - static Signaling
Current Psychopharmacology Novel Indications for Benzodiazepine Antagonist Flumazenil in GABA Mediated Pathological Conditions of the Central Nervous System
Current Pharmaceutical Design Annexins as Neuroprotective Agents in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Crocetin Attenuates Spatial Learning Dysfunction and Hippocampal Injury in a Model of Vascular Dementia
Current Neurovascular Research Personalized Medicine, Bioethics and Social Responsibilities: Re-thinking the Pharmaceutical Industry to Remedy Inequities in Patient Care and International Health
Current Pharmacogenomics and Personalized Medicine Editorial (Thematic Issue: Old Facts and New Perspectives to Face Alzheimer’s Dementia. Focus on Non Neuronal Participants to Neurodegeneration)
CNS & Neurological Disorders - Drug Targets miR-132 Down-regulates Methyl CpG Binding Protein 2 (MeCP2) During Cognitive Dysfunction Following Chronic Cerebral Hypoperfusion
Current Neurovascular Research A Link Between Brain Insulin Resistance and Cognitive Dysfunctions: Targeting Ca2+/cAMP Signalling
Central Nervous System Agents in Medicinal Chemistry Disrupted Structural Brain Network in AD and aMCI: A Finding of Long Fiber Degeneration
Current Alzheimer Research Recent Progress in the Medicinal Chemistry of γ-Secretase Inhibitors
Current Topics in Medicinal Chemistry Recent Topics on Pharmacotherapy for Amphetamine-Type Stimulants Abuse and Dependence
Current Drug Abuse Reviews Hippocampal Subfield Atrophies in Converted and Not-Converted Mild Cognitive Impairments Patients by a Markov Random Fields Algorithm
Current Alzheimer Research Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
Current Neuropharmacology The Role of Genes (and Environmental Stress) in Depression: An Update
Current Psychiatry Reviews Vascular effects of flavonoids
Current Medicinal Chemistry Novel Kynurenic Acid Analogues in the Treatment of Migraine and Neurodegenerative Disorders: Preclinical Studies and Pharmaceutical Design
Current Pharmaceutical Design Understanding the Multifaceted Role of Inflammatory Mediators in Ischemic Stroke
Current Medicinal Chemistry Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease
Current Alzheimer Research Aligning Animal Models of Clinical Germinal Matrix Hemorrhage, From Basic Correlation to Therapeutic Approach
Current Drug Targets Micronutrient Biofortification in Rice through New Breeding Techniques (NBTs): Bangladesh Perspective
Current Nutraceuticals